Income Statement Orion S.A.

Equities

OEC

LU1092234845

Specialty Chemicals

Market Closed - Nyse Other stock markets 16:00:02 2026-01-13 EST			5-day change	1st Jan Change
6.120 ^USD	-0.81%		+5.70%	+15.91%

05:21am	Auking Mining says will not proceed with the Orion acquisition	RE
01-08	Orion Launches Mid-stage Study for Cancer Drug Therapy	MT

d156689309d1f5cc7.kI7BZhXPo27oy7y3mHNadUN7ukqXSILSsnudsHozdJU.xdaHUCC8wi-akv36risSRzEqzxvIee3_hxjuxg5UF-LEwasoIIH1KI6j7Q

Published financial data: ORION S.A.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	1.14B	1.55B	2.03B	1.89B	1.88B
Total Revenues	1.14B	1.55B	2.03B	1.89B	1.88B
Cost of Goods Sold, Total	844M	1.16B	1.58B	1.44B	1.45B
Gross Profit	292M	387M	449M	451M	429M
Selling General & Admin Expenses, Total	186M	215M	227M	213M	238M
R&D Expenses	20.2M	22M	21.7M	24.5M	27.1M
Other Operating Expenses	14.07M	8.6M	2.9M	-700K	1.9M
Other Operating Expenses, Total	220M	246M	252M	237M	267M
Operating Income	72.03M	141M	197M	214M	162M
Interest Expense, Total	-38.67M	-31.6M	-36.4M	-46.9M	-47.8M
Interest And Investment Income	-	-	-	-	-
Net Interest Expenses	-38.67M	-31.6M	-36.4M	-46.9M	-47.8M
Income (Loss) On Equity Invest.	493K	700K	500K	500K	600K
Currency Exchange Gains (Loss)	-	-6.4M	-3.5M	-4M	-1.6M
Other Non Operating Income (Expenses)	-1K	-	-	-	-
EBT, Excl. Unusual Items	33.85M	104M	158M	164M	113M
Restructuring Charges	-7.56M	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-	-	-	-	-
Insurance Settlements	-	-	-	-	-
Legal Settlements	-	82.9M	-	-	-
Other Unusual Items	-	-	-	-	-59.3M
EBT, Incl. Unusual Items	26.29M	186M	158M	164M	53.9M
Income Tax Expense	8.13M	51.7M	51.5M	60.3M	9.7M
Earnings From Continuing Operations	18.16M	135M	106M	104M	44.2M
Net Income to Company	18.16M	135M	106M	104M	44.2M
Net Income - (IS)	18.16M	135M	106M	104M	44.2M
Net Income to Common Incl Extra Items	18.16M	135M	106M	104M	44.2M
Net Income to Common Excl. Extra Items	18.16M	135M	106M	104M	44.2M
Per Share Items
Net EPS - Basic	0.3	2.22	1.74	1.75	0.76
Basic EPS - Continuing Operations	0.3	2.22	1.74	1.75	0.76
Basic Weighted Average Shares Outstanding	60.43M	60.71M	60.9M	59M	58.22M
Net EPS - Diluted	0.3	2.21	1.73	1.73	0.76
Diluted EPS - Continuing Operations	0.3	2.21	1.73	1.73	0.76
Diluted Weighted Average Shares Outstanding	61.41M	60.95M	61.38M	59.98M	58.37M
Normalized Basic EPS	0.35	1.07	1.62	1.74	1.22
Normalized Diluted EPS	0.34	1.06	1.61	1.71	1.21
Dividend Per Share	0.2	0.02	0.08	0.08	0.08
Payout Ratio	66.34	-	4.71	4.73	10.86
Supplemental Items
EBITDA	161M	245M	303M	327M	287M
EBITA	80.23M	149M	204M	220M	169M
EBIT	72.03M	141M	197M	214M	162M
EBITDAR	173M	256M	314M	341M	304M
Effective Tax Rate - (Ratio)	30.93	27.74	32.66	36.81	18
Total Current Taxes	20.28M	31.4M	44.3M	54M	29.4M
Total Deferred Taxes	-12.15M	20.3M	7.2M	6.3M	-19.7M
Normalized Net Income	21.15M	64.69M	98.56M	102M	70.75M
Interest on Long-Term Debt	900K	-	-	-	-
Non-Cash Pension Expense	1.06M	900K	1.4M	2.4M	2.4M
Supplemental Operating Expense Items
Selling and Marketing Expenses	-	-	-	-	-
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	20.2M	22M	21.7M	24.5M	27.1M
Net Rental Expense, Total	11.6M	11.4M	11.7M	14M	16.4M
Imputed Operating Lease Interest Expense	4.72M	3.41M	3.62M	5.41M	6.42M
Imputed Operating Lease Depreciation	6.88M	7.99M	8.08M	8.59M	9.98M
Stock-Based Comp., COGS (Total)	299K	-	-	-	-
Stock-Based Comp., R&D Exp. (Total)	265K	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	3.87M	-	-	-	-
Stock-Based Comp., Other (Total)	-	5.2M	7.7M	15.4M	15.3M
Total Stock-Based Compensation	4.43M	5.2M	7.7M	15.4M	15.3M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	64.87M	65.7M	60.8M	37.5M	44.2M
Short Term Investments	-	17.5M	18.7M	15.6M	9.9M
Total Cash And Short Term Investments	64.87M	83.2M	79.5M	53.1M	54.1M
Accounts Receivable, Total	235M	289M	368M	241M	212M
Other Receivables	53.03M	36.9M	19.4M	24.9M	12.6M
Notes Receivable	-	-	-	-	-
Total Receivables	288M	326M	387M	266M	224M
Inventory	141M	230M	278M	287M	290M
Prepaid Expenses	1.98M	-	-	-	-
Restricted Cash	-	2.8M	2.6M	2.7M	500K
Other Current Assets, Total	4.33M	23.4M	31.3M	37.3M	43.8M
Total Current Assets	500M	665M	778M	646M	613M
Gross Property Plant And Equipment	1.11B	1.29B	1.59B	1.77B	1.89B
Accumulated Depreciation	-589M	-612M	-670M	-763M	-810M
Net Property Plant And Equipment	520M	677M	916M	1.01B	1.08B
Long-term Investments	5.64M	5.3M	14.6M	9.7M	8M
Goodwill	84.48M	78M	73.4M	76.1M	71.5M
Other Intangibles, Total	46.77M	36.3M	27.8M	25.5M	18.5M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	52.56M	50.4M	29.1M	30M	21.6M
Deferred Charges Long-Term	2.3M	-	-	-	-
Other Long-Term Assets, Total	178M	119M	49.2M	35.3M	41.5M
Total Assets	1.39B	1.63B	1.89B	1.83B	1.86B
Liabilities
Accounts Payable, Total	131M	195M	184M	184M	156M
Accrued Expenses, Total	50.68M	47.2M	46.2M	43.7M	43.6M
Short-term Borrowings	75.64M	150M	256M	135M	251M
Current Portion of Long-Term Debt	6.98M	2.2M	2.3M	2.3M	7.9M
Current Portion of Leases	12.08M	11.6M	10.4M	12.6M	15.2M
Current Income Taxes Payable	23.91M	16.9M	31.3M	34.2M	4.8M
Unearned Revenue Current, Total	922K	-	-	-	-
Other Current Liabilities	23.29M	26.2M	22.5M	29.1M	38.1M
Total Current Liabilities	325M	449M	553M	440M	517M
Long-Term Debt	656M	631M	657M	677M	647M
Long-Term Leases	74.53M	73M	87.9M	100M	106M
Pension & Other Post Retirement Benefits	83.31M	74.4M	50M	60.4M	58.5M
Deferred Tax Liability Non Current	38.77M	61.8M	70M	66.3M	36.5M
Other Non Current Liabilities	31.6M	22.2M	11.6M	10.3M	17.2M
Total Liabilities	1.21B	1.31B	1.43B	1.35B	1.38B
Common Stock, Total	85.32M	85.3M	85.3M	85.3M	85.3M
Additional Paid In Capital	68.5M	71.4M	76.4M	85.6M	84.7M
Retained Earnings	84.41M	218M	319M	418M	457M
Treasury Stock	-8.52M	-6.3M	-8.8M	-70.1M	-82.2M
Comprehensive Income and Other	-48.7M	-48.5M	-12.5M	-39.9M	-69.9M
Total Common Equity	181M	320M	459M	478M	475M
Total Equity	181M	320M	459M	478M	475M
Total Liabilities And Equity	1.39B	1.63B	1.89B	1.83B	1.86B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	60.51M	60.66M	59.98M	57.9M	56.65M
ECS Total Common Shares Outstanding	60.49M	60.66M	60.57M	57.9M	57.24M
Book Value / Share	2.99	5.27	7.58	8.26	8.3
Tangible Book Value	49.76M	205M	358M	377M	385M
Tangible Book Value Per Share	0.82	3.39	5.91	6.51	6.72
Total Debt	825M	868M	1.01B	927M	1.03B
Net Debt	760M	784M	934M	874M	973M
Debt Equivalent of Unfunded Proj. Benefit Obligation	84.43M	75.6M	51.6M	61.8M	60M
Debt Equivalent Oper. Leases	92.8M	91.2M	93.6M	112M	131M
Equity Method Investments, Total	5.64M	5.3M	5M	5.1M	8M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	57.01M	97.1M	108M	114M	104M
Inventories - Work In Process, Total	322K	200K	-	200K	100K
Inventories - Finished Goods, Total	84.13M	132M	170M	173M	186M
Land - (BS)	137M	137M	135M	169M	168M
Machinery, Total	871M	1.07B	1.09B	1.35B	1.39B
Full Time Employees	1.4K	1.48K	1.6K	1.65K	1.66K
Accumulated Allowance for Doubtful Accounts (Supple)	5.79M	2.6M	2.6M	1.2M	1.2M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	18.16M	135M	106M	104M	44.2M
Depreciation & Amortization - CF	88.33M	96.3M	99.1M	107M	118M
Amortization of Goodwill and Intangible Assets - (CF)	8.2M	7.8M	6.6M	6.1M	7.2M
Depreciation & Amortization, Total	96.53M	104M	106M	113M	125M
Amortization of Deferred Charges, Total - (CF)	2.07M	4.1M	1.9M	2.7M	1.5M
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	4.43M	5.2M	7.7M	15.4M	15.3M
Other Operating Activities, Total	-7.01M	11.8M	-1.5M	3.2M	-19.6M
Change In Accounts Receivable	-16.5M	-67.6M	-95.6M	131M	13.8M
Change In Inventories	29.95M	-94.9M	-60.1M	-7.7M	-19.6M
Change In Accounts Payable	-18.73M	65M	9.2M	1.6M	-14.8M
Change In Income Taxes	16.4M	-6.3M	20.3M	-2.1M	-17.8M
Change in Other Net Operating Assets	-12K	-10.9M	-12.8M	-14.9M	-3M
Cash from Operations	125M	145M	81M	346M	125M
Capital Expenditure	-145M	-215M	-233M	-173M	-207M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-	-	-	-
Cash from Investing	-145M	-215M	-233M	-173M	-207M
Short Term Debt Issued, Total	206M	188M	223M	284M	263M
Long-Term Debt Issued, Total	-	213M	47.8M	12.6M	-
Total Debt Issued	206M	402M	271M	297M	263M
Short Term Debt Repaid, Total	-171M	-113M	-108M	-418M	-138M
Long-Term Debt Repaid, Total	-8.19M	-213M	-3M	-3M	-4.1M
Total Debt Repaid	-179M	-326M	-111M	-421M	-142M
Repurchase of Common Stock	-1.2M	-	-4.3M	-65.6M	-26.6M
Common Dividends Paid	-12.04M	-	-5M	-4.9M	-4.8M
Common & Preferred Stock Dividends Paid	-12.04M	-	-5M	-4.9M	-4.8M
Other Financing Activities, Total	-1K	-2.9M	-1.7M	-2.7M	-200K
Cash from Financing	13.54M	73.3M	149M	-197M	89.3M
Foreign Exchange Rate Adjustments	5.75M	-3.2M	-2.6M	800K	-3.4M
Net Change in Cash	-365K	600K	-5.1M	-23.2M	4.5M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	7.93M	37.6M	23.9M	56.1M	47.3M
Levered Free Cash Flow	-23.81M	-126M	-136M	175M	-7.42M
Unlevered Free Cash Flow	-1.71M	-110M	-115M	202M	20.95M
Change In Net Working Capital	2.75M	93.1M	118M	-113M	14.2M
Net Debt Issued / Repaid	26.79M	76.2M	160M	-124M	121M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.4	5.83	7	7.19	5.49
Return on Total Capital	4.77	8.02	9.26	9.3	6.96
Return On Equity %	9.89	53.8	27.26	22.07	9.27
Return on Common Equity	9.89	53.8	27.26	22.07	9.27
Margin Analysis
Gross Profit Margin %	25.73	24.99	22.1	23.81	22.84
SG&A Margin	16.37	13.91	11.18	11.25	12.67
EBITDA Margin %	14.19	15.83	14.91	17.28	15.3
EBITA Margin %	7.06	9.61	10.03	11.63	9.01
EBIT Margin %	6.34	9.1	9.7	11.31	8.63
Income From Continuing Operations Margin %	1.6	8.71	5.23	5.46	2.35
Net Income Margin %	1.6	8.71	5.23	5.46	2.35
Net Avail. For Common Margin %	1.6	8.71	5.23	5.46	2.35
Normalized Net Income Margin	1.86	4.18	4.85	5.41	3.77
Levered Free Cash Flow Margin	-2.1	-8.16	-6.67	9.26	-0.4
Unlevered Free Cash Flow Margin	-0.15	-7.14	-5.65	10.67	1.12
Asset Turnover
Asset Turnover	0.86	1.02	1.15	1.02	1.02
Fixed Assets Turnover	2.41	2.58	2.38	1.97	1.79
Receivables Turnover (Average Receivables)	5.08	5.91	6.19	6.22	8.29
Inventory Turnover (Average Inventory)	5.51	6.25	6.23	5.11	5.02
Short Term Liquidity
Current Ratio	1.54	1.48	1.41	1.47	1.19
Quick Ratio	1.09	0.91	0.84	0.72	0.54
Operating Cash Flow to Current Liabilities	0.39	0.32	0.15	0.79	0.24
Days Sales Outstanding (Average Receivables)	72.04	61.79	59.01	58.66	44.14
Days Outstanding Inventory (Average Inventory)	66.4	58.41	58.56	71.46	72.95
Average Days Payable Outstanding	64.12	47.7	42.45	46.23	42.84
Cash Conversion Cycle (Average Days)	74.33	72.5	75.13	83.9	74.26
Long Term Solvency
Total Debt/Equity	455.79	271.35	220.64	193.77	216.36
Total Debt / Total Capital	82.01	73.07	68.81	65.96	68.39
LT Debt/Equity	403.48	220.27	162.15	162.51	158.66
Long-Term Debt / Total Capital	72.6	59.32	50.57	55.32	50.15
Total Liabilities / Total Assets	86.98	80.4	75.68	73.9	74.43
EBIT / Interest Expense	1.86	4.46	5.41	4.57	3.39
EBITDA / Interest Expense	4.47	8.11	8.64	7.28	6.35
(EBITDA - Capex) / Interest Expense	0.72	1.32	2.24	3.59	2.03
Total Debt / EBITDA	4.77	3.38	3.22	2.72	3.38
Net Debt / EBITDA	4.4	3.06	2.97	2.56	3.21
Total Debt / (EBITDA - Capex)	29.56	20.85	12.41	5.51	10.59
Net Debt / (EBITDA - Capex)	27.23	18.85	11.43	5.19	10.04
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-23.03	36.11	31.3	-6.75	-0.87
Gross Profit, 1 Yr. Growth %	-24.98	32.26	16.09	0.49	-4.92
EBITDA, 1 Yr. Growth %	-32.53	48.42	23.64	8.06	-12.19
EBITA, 1 Yr. Growth %	-50.99	93.99	37.08	8.15	-23.2
EBIT, 1 Yr. Growth %	-52.23	105.85	39.99	8.68	-24.37
Earnings From Cont. Operations, 1 Yr. Growth %	-79.11	640.11	-21.16	-2.54	-57.29
Net Income, 1 Yr. Growth %	-79.11	640.11	-21.16	-2.54	-57.29
Normalized Net Income, 1 Yr. Growth %	-72.65	242.72	52.37	3.87	-30.89
Diluted EPS Before Extra, 1 Yr. Growth %	-78.87	636.67	-21.72	0	-56.12
Accounts Receivable, 1 Yr. Growth %	10.46	23.04	27.31	-34.48	-12.07
Inventory, 1 Yr. Growth %	-14.16	62.4	20.93	3.31	1.15
Net Property, Plant and Equip., 1 Yr. Growth %	22.83	30.3	15.6	10.33	7.14
Total Assets, 1 Yr. Growth %	10.53	17.36	15.8	-2.93	1.3
Tangible Book Value, 1 Yr. Growth %	-14.32	313.28	74.39	5.22	2.12
Common Equity, 1 Yr. Growth %	-2.69	76.63	43.7	4.16	-0.75
Cash From Operations, 1 Yr. Growth %	-45.89	15.88	-44.21	327.04	-63.78
Capital Expenditures, 1 Yr. Growth %	-7	48.17	8.43	-25.77	19.62
Levered Free Cash Flow, 1 Yr. Growth %	-144.91	785.36	7.46	-229.43	-104.23
Unlevered Free Cash Flow, 1 Yr. Growth %	-102.51	6.55K	3.81	-276.16	-89.63
Dividend Per Share, 1 Yr. Growth %	-75	-89.65	314	3.5	3.5
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-15.14	2.36	33.68	10.65	-3.85
Gross Profit, 2 Yr. CAGR %	-17.54	-0.4	23.91	8.01	-2.25
EBITDA, 2 Yr. CAGR %	-22.69	0.2	37.1	15.59	-2.59
EBITA, 2 Yr. CAGR %	-35.3	-3.66	67.39	21.76	-8.86
EBIT, 2 Yr. CAGR %	-35.23	-2.2	74.81	23.34	-9.34
Earnings From Cont. Operations, 2 Yr. CAGR %	-61.31	24.5	141.56	-12.34	-35.49
Net Income, 2 Yr. CAGR %	-61.31	24.5	141.56	-12.34	-35.49
Normalized Net Income, 2 Yr. CAGR %	-51.45	-7.21	144.87	25.8	-15.28
Diluted EPS Before Extra, 2 Yr. CAGR %	-61.17	24.75	140.14	-11.52	-33.76
Accounts Receivable, 2 Yr. CAGR %	-5.48	16.58	25.16	-8.67	-24.1
Inventory, 2 Yr. CAGR %	-12.23	18.09	40.14	11.77	2.22
Net Property, Plant and Equip., 2 Yr. CAGR %	16.13	26.51	32.76	12.93	8.72
Total Assets, 2 Yr. CAGR %	4.49	13.89	16.58	6.02	-0.83
Tangible Book Value, 2 Yr. CAGR %	147.78	88.06	168.46	35.46	3.66
Common Equity, 2 Yr. CAGR %	6.73	31.1	59.31	22.34	1.67
Cash From Operations, 2 Yr. CAGR %	1.34	-20.8	-19.6	54.34	24.38
Capital Expenditures, 2 Yr. CAGR %	11.7	17.39	26.75	-10.29	-5.77
Levered Free Cash Flow, 2 Yr. CAGR %	-7.66	54.24	185.03	17.94	-76.6
Unlevered Free Cash Flow, 2 Yr. CAGR %	-80.19	29.47	429.05	35.23	-57.26
Dividend Per Share, 2 Yr. CAGR %	-50	-83.91	-35.66	103.47	1.73
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-5.07	-0.67	11.21	18.56	6.67
Gross Profit, 3 Yr. CAGR %	-8.18	-3.48	4.82	15.55	3.51
EBITDA, 3 Yr. CAGR %	-11.54	-3.18	7.48	26.64	5.47
EBITA, 3 Yr. CAGR %	-19.88	-8.13	8.36	44.71	4.42
EBIT, 3 Yr. CAGR %	-18.81	-6.39	10.22	49.19	4.79
Earnings From Cont. Operations, 3 Yr. CAGR %	-34.58	3.55	6.91	78.49	-31.03
Net Income, 3 Yr. CAGR %	-34.58	3.55	6.91	78.49	-31.03
Normalized Net Income, 3 Yr. CAGR %	-28.11	-10.35	9.47	83.99	3.03
Diluted EPS Before Extra, 3 Yr. CAGR %	-34.55	3.56	6.8	79.33	-29.97
Accounts Receivable, 3 Yr. CAGR %	0.07	3.2	20.05	0.87	-9.82
Inventory, 3 Yr. CAGR %	-3.89	7.76	19.03	26.6	8.11
Net Property, Plant and Equip., 3 Yr. CAGR %	7.74	20.67	29.36	24.81	10.97
Total Assets, 3 Yr. CAGR %	6.08	8.61	14.52	9.67	4.43
Tangible Book Value, 3 Yr. CAGR %	13.99	193.73	83.39	96.47	23.29
Common Equity, 3 Yr. CAGR %	23.84	26.24	35.17	38.27	14.1
Cash From Operations, 3 Yr. CAGR %	-5.35	5.98	-29.53	40.28	-4.79
Capital Expenditures, 3 Yr. CAGR %	17.09	22.72	14.32	6.05	-1.26
Levered Free Cash Flow, 3 Yr. CAGR %	-16.1	65.32	36.74	119.08	-61.1
Unlevered Free Cash Flow, 3 Yr. CAGR %	-70.06	36.34	20.28	266.69	-42.55
Dividend Per Share, 3 Yr. CAGR %	-36.2	-70.42	-53.05	-25.47	60.57
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-3.53	6.31	8.86	3.71	4.92
Gross Profit, 5 Yr. CAGR %	-5.69	0.64	3.52	0.96	1.93
EBITDA, 5 Yr. CAGR %	-8.68	0.56	5.39	3.93	3.33
EBITA, 5 Yr. CAGR %	-13.42	-3.02	5.48	2.82	1.11
EBIT, 5 Yr. CAGR %	-15.26	-1.26	7.93	4.53	1.93
Earnings From Cont. Operations, 5 Yr. CAGR %	-19.12	22.16	10.36	-3.13	-12.65
Net Income, 5 Yr. CAGR %	-19.12	22.16	10.36	-3.13	-12.65
Normalized Net Income, 5 Yr. CAGR %	-18.9	-0.82	11.6	2.66	-1.19
Diluted EPS Before Extra, 5 Yr. CAGR %	-19.35	21.93	10.09	-2.76	-11.77
Accounts Receivable, 5 Yr. CAGR %	2.2	7.51	9.44	-1.72	-0.06
Inventory, 5 Yr. CAGR %	1.93	13.74	11.77	9.35	12
Net Property, Plant and Equip., 5 Yr. CAGR %	3.79	12.52	17.13	21.26	20.67
Total Assets, 5 Yr. CAGR %	3.2	9.12	10.16	7.57	8.11
Tangible Book Value, 5 Yr. CAGR %	-15.36	21.46	60.53	115.52	45.97
Common Equity, 5 Yr. CAGR %	24.39	41.77	36.97	24.67	20.62
Cash From Operations, 5 Yr. CAGR %	-13.73	-3.93	-11.33	23.18	-11.55
Capital Expenditures, 5 Yr. CAGR %	18.11	24.82	20.86	8.27	5.82
Levered Free Cash Flow, 5 Yr. CAGR %	-30.52	1.98	27.45	44.43	-32.51
Unlevered Free Cash Flow, 5 Yr. CAGR %	-60.38	-3.89	12.48	35.89	-20.49
Dividend Per Share, 5 Yr. CAGR %	-24.58	-51.1	-35.98	-36.47	-36.47